VR Logo

Fortis Healthcare: Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.


This is in continuation of our intimation dated October 18 2018 December 22 2018 March 20 2019 November 13 2020 and November 21 2020 with respect to an ad-interim ex-parte order passed by SEBI in the matter relating to the alleged diversion of funds from the Company by its erstwhile promoters. SEBI has issued a notice under Rule 4 of SEBI (Procedure for holding inquiry and imposing penalties) Rules 1995 read with Section 15-I of Securities and Exchange Board of India Act 1992 in the matter of Fortis Healthcare Limited to among others Escorts Heart Institute and Research Center Limited (EHIRCL) a wholly owned subsidiary of the Company. The notice was received by EHIRCL on April 15 2021. The management and Board of the Company that was newly constituted after NTK Ventures Pte. Ltd. (a wholly owned subsidiary of IHH Healthcare Berhad) became promoters of the Company are evaluating the notice received by EHIRCL in consultation with its legal advisors.

Click here to view PDF